4 sources checked · source map still forming · 1h ago
Needs Review
Ozempic, Wegovy users sue over rare, permanent blindness
Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
0 Left4 Center0 Right
Needs review.This source map is too narrow, too early, or mixed-format to trust yet.
NEEDS REVIEW
As of September 26, 2026 at 10:00 AM, this is how Optics News reads the wording differences in this story.
What happenedOver 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
The headline splitThe headlines are mostly aligned. The differences are small wording choices, not a major framing split.
Match confidenceDeveloping. Only 4 sources are matched, and the source map is still narrow. Useful to watch, not enough to draw conclusions yet.
Same-event confidenceDeveloping
Not enough sources yet to confirm this is the same specific event.
Framing confidenceHidden
Wording-gap score not shown — same-event match is still developing.
Wording differs, but the match is too narrow to read confidently yet.
WHAT EACH SIDE EMPHASIZED
Left / center-leftNo matching source in this bucket yet.
Optics keeps watching for pickup.
CenterOzempic, Wegovy users sue over rare, permanent blindness
The Plain Dealer (Cleveland.com) · Center · News report
Right / center-rightNo matching source in this bucket yet.
Ozempic, Wegovy users sue over rare, permanent blindness
Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
Ozempic, Wegovy users sue over rare, permanent blindness
Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
Ozempic, Wegovy users sue over rare, permanent blindness
Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
Ozempic, Wegovy users sue over rare, permanent blindness
Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.
